Clinical Trial: A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients

U.S., Nov. 15 -- ClinicalTrials.gov registry received information related to the study (NCT04139252) titled 'A National Study for Blood Based Response Monitoring of B-cell Lymphoma Patients' on Oct. 23.

Brief Summary: Observational prospective study. Patients with DLBCL and HGBCL will be enrolled in the study to collect samples for developing a blood based assay allowing biomarker driven treatment in the future.

Study Type: Observational

Condition: NHL

Intervention: Other: No intervention

No intervention

Recruitment Status: Not Yet Recruiting

Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland

Information provided by (Responsible Party): Stichting Hemato-Oncologie voor Volwassenen Nederland

Published by HT Digital Conten...